Drugs Made Valuation
| DMAA Stock | 10.44 0.01 0.1% |
At this time, the firm appears to be overvalued. Drugs Made In shows a prevailing Real Value of USD8.74 per share. The current price of the firm is USD10.44. Our model computes the value of Drugs Made In from reviewing the firm fundamentals such as Shares Owned By Insiders of 26.77 %, market capitalization of 349.58 M, and Short Ratio of 5.20 X as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Drugs Made's valuation include:
Overvalued
Today
Please note that Drugs Made's price fluctuation is very steady at this time. Calculation of the real value of Drugs Made In is based on 3 months time horizon. Increasing Drugs Made's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Drugs Made is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Drugs Stock. However, Drugs Made's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 10.44 | Real 8.74 | Hype 10.44 | Naive 10.44 |
The real value of Drugs Stock, also known as its intrinsic value, is the underlying worth of Drugs Made In Company, which is reflected in its stock price. It is based on Drugs Made's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Drugs Made's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Drugs Made In helps investors to forecast how Drugs stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Drugs Made more accurately as focusing exclusively on Drugs Made's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Drugs Made's intrinsic value based on its ongoing forecasts of Drugs Made's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Drugs Made's closest peers. If more than one evaluation category is relevant for Drugs Made we suggest using both methods to arrive at a better estimate.
About Drugs Made Valuation
The stock valuation mechanism determines Drugs Made's current worth on a weekly basis. Our valuation model uses a comparative analysis of Drugs Made. We calculate exposure to Drugs Made's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Drugs Made's related companies.Drugs Made Current Valuation Indicators
Valuation refers to the process of determining the present value of Drugs Made In and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Drugs we look at many different elements of the entity such as Drugs's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Drugs Made, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Drugs Made's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Drugs Made's worth.Complementary Tools for Drugs Stock analysis
When running Drugs Made's price analysis, check to measure Drugs Made's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Drugs Made is operating at the current time. Most of Drugs Made's value examination focuses on studying past and present price action to predict the probability of Drugs Made's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Drugs Made's price. Additionally, you may evaluate how the addition of Drugs Made to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |